Skip to Content


Active Substance: telmisartan / amlodipine besilate
Common Name: telmisartan / amlodipine
ATC Code: C09DB04
Marketing Authorisation Holder: Boehringer Ingelheim International GmbH
Active Substance: telmisartan / amlodipine besilate
Status: Withdrawn
Authorisation Date: 2011-11-24
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Cardiovascular system

Therapeutic Indication

Treatment of essential hypertension in adults:

Add on therapy

Onduarp is indicated in adults whose blood pressure is not adequately controlled on amlodipine.

Replacement therapy

Adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of Onduarp containing the same component doses.

The marketing authorisation for Onduarp has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.